Trial Profile
Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis After Loading Dose of Clopidogrel
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms SAMPA
- 19 Oct 2014 Status changed from recruiting to completed, as reported by ClinicalTrials.gov
- 20 Aug 2014 New trial record